The prevalent model for Alzheimer's disease (AD) pathogenesis proposes that dysfunctional metabolism of the amyloid precursor protein (APP) leads to the formation of β‐amyloid (Aβ) plaques derived from Aβ42 cleavage products of APP that drive disease progression [98]. This evidence concerns the gene APP and Alzheimer disease.